tsemisphere biosciences logo

Investor Relations


Corporate Profile    Stock Quote
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Emisphere Technologies, Inc.'s financial performance into perspective.  
EMIS (Common)
Exchange BB
Price $1.00
Change (%) +0.02 (up2.04%)
Volume 66,600
Data as of Feb 8, 2010 3:10 PM ET
Minimum 20 minute delay
Refresh quote
Feb 9, 2010 at 2:30 PM
12th Annual BIO CEO & Investor Conference
 
 
Recent Releases
Feb 2, 2010
Emisphere to Present at 12th Annual BIO CEO & Investor Conference

Jan 13, 2010
Novo Nordisk Starts Phase I Trial with Long-Acting Oral GLP-1 Analogue

Dec 21, 2009
Meta-Analysis of Independent Research Supports Potential for Oral Salmon Calcitonin Using Emisphere's Eligen(R) Technology as Therapeutic Option for Persistent Musculoskeletal Pain


Copyright © Emisphere, All rights reserved